Alexander Awgulewitsch, Ph.D.
Associate Professor
Rheumatology/Immunology
Transgenic mouse models for skin cancer and the role of Hox genes in skin development & cancer

Craig Beeson, Ph.D.
Associate Professor
Department of Pharmaceutical Sciences
Development of topoisomerase I inhibitors

Narayan R. Bhat, Ph.D.
Professor
Department of Neurology
Growth factor signaling and gliomagenesis

Robert J. Boackle, Ph.D.
Professor of Immunology
Professor and Director of Oral Biology, Department of Stomatology
Mucosal immunity, inflammation, mucosal defense against HIV, complement chemistry, cancer immunotherapy

Maria G. Buse, M.D.
Professor, Division of Endocrinology
Cell regulation and hormones in relation to cancer

David J. Cole, M.D.
Professor
Department of Surgery
Mechanisms of T-cell recognition of tumor antigens to translate into ongoing clinical cancer vaccine/gene therapy trials

Weiman Fan, M.D., M.P.H.
Professor
Department of Pathology and Laboratory Medicine
Molecular Oncology, experimental therapeutics, and tumor growth regulation

Sebastiano Gattoni-Celli, M.D.
Professor
Radiation Oncology
Immunotherapy of cancer

Yusuf A. Hannun, M.D.
Ralph F. Hirschmann Professor and Chairman
Biochemistry and Molecular Biology
Tumor promotion/apoptosis, cancer therapeutics

Stanley R. Hoffman, Ph.D.
Professor
Rheumatology/Immunology
Function of specific ECM proteins and MMP's in metastasis & tumaor angiogenesis

Tien Hsu, Ph.D.
Associate Professor
Hollings Cancer Center
Drosophila model systems for studying cancer-related gene functions

Michael Kern, Ph.D.
Associate Professor
Cell Biology & Anatomy
Target genes of homeobox transcription factors in cancer: microarrays and beyond.

Steven W. Kubalak, Ph.D.
Associate Professor
Cell Biology & Anatomy
Transforming growth factor-beta regulation of apoptosis

Dhandapani Kuppuswamy, Ph.D.
Associate Professor
Department of Medicine, Division of Cardiology
Use terminally differentiated cardiac cells to identify factors that could negatively influence cancer cell growth

Runzhao Li, M.D., M.Sc.
Assistant Professor
Department of Medicine
Center for Molecular & Structural Biology
Modulation of Ets transcription factors in tumor angiogenesis and apoptosis protein-protein interaction and the signals in transcriptional control of Ets target genes. Gene therapy, application of tumor suppressor genes and oncogenes for developing new anti-neoplastic targets.

Michael Mitas, M.D.
Assistant Professor
Department of Surgery
Breast cancr diagnostics and detection of associated genes

Robin C. Muise-Helmericks, Ph.D.
Assistant Professor
Cell Biology and Anatomy
Hollings Cancer Institute
Role of the Ets family of transcription factors in angiogenesis and lymphoid development

Dr. James S. Norris, Ph.D.
Professor and Chairman
Microbiology & Immunology
Apoptosis & apoptosis signaling, bystander effect, ceramide, combined chemotherapy-gene therapy, and apoptosis inducing gene FasL, TRAIL, & BAX

Lina M. Obeid, M.D.
Professor
Role of sphingolipids in tumor angiogenesis

Makio Ogawa, M.D., Ph.D.
Professor
Department of Pathology & Laboratory Med
Division of Experimental Hematology
Differentiation and proliferation of hemopoietic stem cells

Besim Ogretmen, Ph.D.
Assistant Professor
Department of Biochemistry
Regulation of telomerase and roles of sphingolipids in cancer chemotherapy

Swapan K. Ray, Ph.D.
Assistant Professor
Department of Neurology
Involvement of calpain, a Ca2+-dependent cysteine protease, in the molecular mechanisms of cell death in disorders and diseases of the central nervous system

Steven A. Rosenzweig, Ph.D.
Professor
Cell and Molecular Pharmacology
Tumorigenesis, angiogenesis, hypoxia-inducible factor, IGF-binding proteins, receptor tyrosine kinases, and protein:protein interactions

Clifford W. Schweinfest, Ph.D.
Professor
Department of Experimental Oncology
The role of the growth suppressor gene, DRA, in colorectal neoplasia and the role of mismatch repair genes in prostate cancer

Eleanor K. Spicer, Ph.D.
Associate Professor
Biochemistry and Molecular Biology
Post-transcriptional regulation of human bcl-2 expression

Demetri D. Spyropoulos, Ph.D.
Assistant Professor
Department of Medicine
Lymphoid, breast, bladder, prostate, & colon cancer

Stephen Tomlinson, Ph.D.
Associate Professor
Microbiology & Immunology
Role of complement & complement inhibitors in tumorigenesis and immune response to cancer

Bryan Toole, Ph.D.
Professor
MCBP
Hyaluronan and emmprin in cell survival signaling pathways, multidrug resistance, epithelial-mesenchymal transition, angiogenesis and invasiveness in cancer

Maria Trojanowska, Ph.D.
Professor
Rheumatology/Immunology
The role of stromal cells in tumor growth and progression

Irene Y. Wang, Ph.D.
Associate Professor
Biochemistry and Molecular Biology
Construction and expression of mouse-human chimeric antibodies toward human colon and lung cancers

Dennis K. Watson, Ph.D.
Professor
Laboratory of Cancer Genomics
Pathology & Laboratory Medicine
Mechanisms of cancer initiation, progression, and metastasis

M. Rita I. Young, Ph.D.
Professor of Medicine
Department of Hematology Oncology
Cancer motility, Angiogenesis, Imunotherapy

Daohong Zhou, M.D.
Professor
Department of Pathology & Laboratory Med
Elucidate the cellular & molecular mechanisms by which ionizing radiation (IR) and chemotherapy cause normal tissure damage & develop new interventions to ameliorate IR and chemotherapy-induced bone marrow suppression.